Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516244 | 1.00 | TSHR (0.47) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL2047233 | 0.93 | TSHR (0.47) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL508210 | 0.91 | MIF (0.43) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL8401752 | 0.91 | MIF (0.43) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL9136636 | 0.88 | TSHR (0.43) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL28416749 | 0.87 | TSHR (0.40) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL287022 | 0.87 | TSHR (0.43) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL28273815 | 0.86 | TSHR (0.42) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL25895341 | 0.83 | TSHR (0.40) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 | |
| SCHEMBL30305073 | 0.82 | ALDH1A1 (0.38) | TSHRCYP3A4TP53MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 907 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026055875-A9 | ONE-COMPONENT (1K) HEAT-ACTIVATABLE WATERBORNE POLYURETHANE ADHESIVE AND USE THEREOF | HENKEL AG & CO. KGAA (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260066464-A1 | BATTERY SUBSTRATE FOR SEPARATING POSITIVE ELECTRODE AND NEGATIVE ELECTRODE FROM EACH OTHER IN RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY COMPRISING SAME | SAMSUNG SDI CO LTD (KR) | 2026-03-05 | — | — | US | claimed |
| CN-117645638-A | Fullerene derivative, and preparation method and application thereof | 中国科学院化学研究所 | 2024-03-05 | — | — | CN | claimed |
| US-20230192725-A1 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | LANXESS ORGANOMETALLICS GMBH (DE) | 2023-06-22 | — | — | US | claimed |
| EP-4153602-A1 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | LANXESS Organometallics GmbH (DE) | 2023-03-29 | — | — | EP | claimed |
| CN-110511188-B | Preparation method of 2-imino dihydro quinazolinone compound | 烟台大学 | 2022-09-20 | — | — | CN | claimed |
| US-11292890-B2 | Curable resin composition and sealing material using same | NIPPON SHOKUBAI CO., LTD. (JP) | 2022-04-05 | — | — | US | claimed |
| WO-2021233930-A1 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | LANXESS ORGANOMETALLICS GMBH (DE) | 2021-11-25 | — | — | WO | claimed |
| WO-2021079380-A1 | IMPROVED PROCESS FOR THE PREPARATION OF (2S)-N-{(1S)-1-(2-CHLOROPHENYL)-2-[(3,3-DIFLUOROCYCLOBUTYL)-AMINO]-2-OXOETHYL}-1-(4-CYANOPYRIDIN-2-YL)-N-(5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2021-04-29 | — | — | WO | claimed |
| WO-2020133337-A1 | THERMOSETTING RESIN COMPOSITION, AND PREPREG, LAMINATED BOARD AND HIGH FREQUENCY CIRCUIT SUBSTRATE WHICH CONTAIN SAME | 广东生益科技股份有限公司 | 2020-07-02 | — | — | WO | claimed |
| WO-2012048271-A1 | PHOSPHORAMIDATE DERIVATIZATION OF INORGANIC POLYPHOSPHATES AND METHODS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-04-12 | — | — | WO | claimed |
| US-20120064453-A1 | PROCESSES FOR PRODUCING POLYESTER LATEXES WITH IMPROVED HYDROLYTIC STABILITY | XEROX CORPORATION (US) | 2012-03-15 | — | — | US | claimed |
| US-6846901-B1 | Liquid initiator for accelerating the progress of the anionic lactam polymerization, method for producing the same and the use thereof | EMS-CHEMIE AG (CH) | 2005-01-25 | — | — | US | claimed |
| EP-1242507-B1 | LIQUID INITIATOR FOR ACCELERATING THE PROGRESS OF THE ANIONIC LACTAM POLYMERIZATION, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF | EMS CHEMIE AG (CH) | 2003-10-29 | — | — | EP | claimed |
| EP-1242507-A1 | LIQUID INITIATOR FOR ACCELERATING THE PROGRESS OF THE ANIONIC LACTAM POLYMERIZATION, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF | EMS-Chemie AG (CH) | 2002-09-25 | — | — | EP | claimed |
| WO-2001046292-A1 | LIQUID INITIATOR FOR ACCELERATING THE PROGRESS OF THE ANIONIC LACTAM POLYMERIZATION, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF | EMS-CHEMIE AG (CH) | 2001-06-28 | — | — | WO | claimed |
| EP-0872508-B1 | Process for preparing a storage stable liquid system for the anionic lactam polymerisetion | INVENTA AG (CH) | 2000-08-16 | — | — | EP | claimed |
| US-6013758-A | FORMING LACTAMATE SALT WITH STRONG BASE REACTED WITH DISSOLVED LACTAM, THEN REACTING RESULTING LACTAMATE WITH ACTIVATOR, COOLING LIQUID, STORAGE STABLE REACTION PRODUCT; SIMPLIFICATION | EMS-INVENTA AG (CH) | 2000-01-11 | — | — | US | claimed |
| EP-0872508-A1 | Process for preparing a storage stable liquid system for the anionic lactam polymerisetion | EMS-INVENTA AG (CH) | 1998-10-21 | — | — | EP | claimed |
| US-4075150-A | COMPOSITION FOR CURING POLYURETHANES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-02-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192725-A1 | NOVEL ORGANO-MAGNESIUM COMPOUNDS AND THEIR USE | DDO, MGAM2, MGAM | TSHR 4363/4885CYP3A4 1242/4885TP53 3163/4885 |
| US-20260066464-A1 | BATTERY SUBSTRATE FOR SEPARATING POSITIVE ELECTRODE AND NEGATIVE ELECTRODE FROM EACH OTHER IN RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY COMPRISING SAME | HSPB1, HSPA1B, HSPBP1 | TSHR 2251/4885CYP3A4 4184/4885TP53 2842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.